DK0951281T3 - 2-cyclopenten-1-on og derivater heraf som inhibitorer af NF-kappaB-faktoren - Google Patents

2-cyclopenten-1-on og derivater heraf som inhibitorer af NF-kappaB-faktoren

Info

Publication number
DK0951281T3
DK0951281T3 DK97954382T DK97954382T DK0951281T3 DK 0951281 T3 DK0951281 T3 DK 0951281T3 DK 97954382 T DK97954382 T DK 97954382T DK 97954382 T DK97954382 T DK 97954382T DK 0951281 T3 DK0951281 T3 DK 0951281T3
Authority
DK
Denmark
Prior art keywords
cyclopenten
inhibitors
derivatives
factor
kappab
Prior art date
Application number
DK97954382T
Other languages
English (en)
Inventor
Maria Gabriella Santoro
Antonio Rossi
Giuliano Elia
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Application granted granted Critical
Publication of DK0951281T3 publication Critical patent/DK0951281T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97954382T 1996-12-13 1997-12-11 2-cyclopenten-1-on og derivater heraf som inhibitorer af NF-kappaB-faktoren DK0951281T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000867A IT1289250B1 (it) 1996-12-13 1996-12-13 Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb

Publications (1)

Publication Number Publication Date
DK0951281T3 true DK0951281T3 (da) 2006-10-30

Family

ID=11404593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97954382T DK0951281T3 (da) 1996-12-13 1997-12-11 2-cyclopenten-1-on og derivater heraf som inhibitorer af NF-kappaB-faktoren

Country Status (12)

Country Link
US (2) US6392100B1 (da)
EP (2) EP0951281B9 (da)
JP (1) JP2001505900A (da)
AT (1) ATE331504T1 (da)
AU (1) AU5855798A (da)
CA (1) CA2274108C (da)
DE (1) DE69736243T2 (da)
DK (1) DK0951281T3 (da)
ES (1) ES2268739T3 (da)
IT (1) IT1289250B1 (da)
PT (1) PT951281E (da)
WO (1) WO1998025593A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050020687A1 (en) * 1996-01-14 2005-01-27 Consiglio Nazionale Ricerche Methods of treating inflammatory and viral disorders by administering cyclopentenone compounds
IT1289250B1 (it) 1996-12-13 1998-09-29 Consiglio Nazionale Ricerche Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb
AU5195799A (en) * 1998-08-18 2000-03-14 Takara Shuzo Co., Ltd. Remedies or preventives containing cyclopentenone compounds as the active ingredient
WO2000056341A1 (en) * 1999-03-22 2000-09-28 Charterhouse Therapeutics Ltd. Chemical compounds and their uses
GB9929702D0 (en) * 1999-12-16 2000-02-09 Charterhouse Therapeutics Ltd Chemical compounds and their uses
JPWO2002036547A1 (ja) * 2000-11-01 2004-03-11 味の素株式会社 シクロプロパンカルボン酸アミド化合物及びその医薬用途
DE10300222A1 (de) * 2003-01-03 2004-07-15 MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen
US8129345B2 (en) * 2006-07-20 2012-03-06 Dana-Farber Cancer Institute, Inc. MUC1-IκB kinase complexes and their activities
US20080287532A1 (en) * 2007-05-18 2008-11-20 Joseph Schwarz Oxacyclopentene-2 derivatives
WO2017165170A1 (en) * 2016-03-21 2017-09-28 William Marsh Rice University Electron withdrawing group substituted and macrocyclic pgj3 analogs and methods of treatment thereof
CN116874362B (zh) * 2023-06-27 2024-08-16 东海实验室 一类环戊烯酮类化合物及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0131441B1 (en) * 1983-07-06 1989-10-18 Teijin Limited 5-alkylidene-2-halo-4-substituted-2-cyclopentenone and process for production thereof
JPS6097926A (ja) * 1983-11-04 1985-05-31 Teijin Ltd 新規な4−ヒドロキシ−2−シクロペンテノン類およびその製造方法
JPS6147437A (ja) * 1984-08-15 1986-03-07 Teijin Ltd 5―アルキリデン―2―ハロ―4―置換―2―シクロペンテノン類
US4954519A (en) 1987-04-28 1990-09-04 Georgia Tech Research Corporation Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
US4711895A (en) 1984-10-22 1987-12-08 Teijin Limited 4-hydroxy-2-cyclopentenone, process for production thereof, pharmaceutical composition comprising it
JPS6244A (ja) 1985-06-25 1987-01-06 Nippon Iyakuhin Kogyo Kk 2−ハロ−2−シクロペンテノン誘導体及びその製法
JPS6259258A (ja) * 1985-09-09 1987-03-14 Teijin Ltd プナグランジン類およびその製法
US6150090A (en) 1986-01-09 2000-11-21 Massachusetts Institute Of Technology Nuclear factors associated with transcriptional regulation
JPS6372672A (ja) * 1986-09-17 1988-04-02 Teijin Ltd 2−フルオロ−4−ヒドロキシ−2−シクロペンテノン類およびその製造法
AU615534B2 (en) 1988-04-19 1991-10-03 Teijin Limited 2-substituted-2-cyclopentenones
US5216183A (en) 1988-04-19 1993-06-01 Teijin Limited Cyclopentanone/cyclopentenone derivative
US5338844A (en) 1989-10-19 1994-08-16 Teijin Limited 2-substituted-2-cyclopentenone compound and anticancer agent and bone formation accelerator comprising same as active ingredient
JP3185823B2 (ja) * 1993-01-12 2001-07-11 住友電気工業株式会社 インバータ回路
DE4311835A1 (de) 1993-04-07 1994-10-13 Boehringer Ingelheim Int Verfahren zur Inhibierung der Transkription von Genen
JPH07233142A (ja) 1994-02-23 1995-09-05 Teijin Ltd 2,3,4,4,5―五置換―2―シクロペンテノン類の製造法
GB9418762D0 (en) 1994-09-16 1994-11-02 Bayer Ag Use of substituted cyclopentane-DI-and-triones
IT1293069B1 (it) 1997-07-01 1999-02-11 Consiglio Nazionale Ricerche Inibitori di nf-kb come attivatori di hsf e induttori di proteine da shock termico
IT1284853B1 (it) 1996-06-18 1998-05-22 Consiglio Nazionale Ricerche Impiego del 2-ciclopenten-1-one come induttore di hsp70.
IT1289250B1 (it) 1996-12-13 1998-09-29 Consiglio Nazionale Ricerche Impiego di 2 ciclopenten 1-one e suoi derivati come inibitori del fattore nf-kb
CN1117057C (zh) 1996-09-27 2003-08-06 宝酒造株式会社 环戊烯酮及其生产方法和应用
JP2709807B2 (ja) 1996-11-01 1998-02-04 富士薬品工業株式会社 3−クロロ−4−シリルオキシ−2−シクロペンテン−1−オン類の製造法
EA001607B1 (ru) 1997-03-17 2001-06-25 Такара Сузо Ко., Лтд. Антивирусное средство
WO1999000349A1 (en) 1997-06-30 1999-01-07 Takara Shuzo Co., Ltd. Cyclopentenone derivatives

Also Published As

Publication number Publication date
CA2274108C (en) 2010-03-16
EP1704855A2 (en) 2006-09-27
ITRM960867A1 (it) 1998-06-13
EP0951281B9 (en) 2008-02-20
JP2001505900A (ja) 2001-05-08
US20020137800A1 (en) 2002-09-26
US6392100B1 (en) 2002-05-21
IT1289250B1 (it) 1998-09-29
EP1704855A3 (en) 2007-04-18
ES2268739T3 (es) 2007-03-16
WO1998025593A2 (en) 1998-06-18
US6696498B2 (en) 2004-02-24
ATE331504T1 (de) 2006-07-15
PT951281E (pt) 2006-11-30
DE69736243D1 (de) 2006-08-10
EP0951281A2 (en) 1999-10-27
AU5855798A (en) 1998-07-03
EP0951281B1 (en) 2006-06-28
ITRM960867A0 (it) 1996-12-13
DE69736243T2 (de) 2007-06-06
WO1998025593A3 (en) 1998-10-01
CA2274108A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
DK0920429T3 (da) Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
NO954090D0 (no) 1,5 Benzodiazepin-derivater med CCK-antagonistisk eller agonistisk aktivitet
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DK0552031T3 (da) Oxepan-isomere af rapamycin, der er anvendelige som immunsuppressive midler
DK0946512T3 (da) 6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer
DK0951281T3 (da) 2-cyclopenten-1-on og derivater heraf som inhibitorer af NF-kappaB-faktoren
FI912621A0 (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
FI891438A0 (fi) Foerfarande foer framstaellning av farmaceutiska sammansaettningar som inverkar i synnerhet pao det kardiovaskulaera systemet.
MY134008A (en) Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
FI852050L (fi) Tvaettmedelskompositioner anvaendbara som aoterutfaellning av smuts foerhindrande medel, vilka bestaor av pao polyoxietylen och polyoxialkylen baserade kopolymerer, och foerfarande foer framstaellning daerav.
FI874283A (fi) Isolerande produkt framstaelld pao platsen, fibrer och partiklar som ingaor i dess sammansaettning och framstaellningsfoerfarande.
FI912622A0 (fi) Farmakologiskt aktiva foereningar med verkan pao det centrala nervsystemet.
NO20021040D0 (no) Substituerte N-fenyl- 2-hydroksy-2-metyl-3,3,3- trifluoropropanamid-derivater som eleverer puruvatdehydrogenase-aktivitet
DK0935598T3 (da) 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet
DE59504407D1 (de) Längenverstellbare Gasfeder für Stühle, Tische o.dgl.
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
FI83U1 (fi) Limtraebalk eller -fackverk, som monteras pao byggnadsplatsen
FI920314A0 (fi) Pao roerliga tyngder baserat lagringssystem foer vindkraft som tillvaratas med hjaelp av en vaederkvarn.
FI930880A0 (fi) Loesning pao parkering av bilar, dvs. parkeringsloesning
FI941868A0 (fi) Foerfarande foer hantering av avfallskaerl i anslutning till sopbil och motsvarande anordningar
FI921397A0 (fi) Foerfarande foer flyttning av fordon, pao hjul gaoende fordon och krypbandstruktur.
FI892445A0 (fi) Foerfarande foer avlaegsnande av vatten fraon en bana som haoller pao att bildas, speciellt en pappersbana.
FI925599A0 (fi) Foersaelnings- och exponeringsstaell foer artiklar som foervaras i rullar, t.ex. plastgraesmattor, korridormattor och slaskmattor
ITRM20010648A0 (it) Linee cellulari per l'incapsidazione di vettori sv40 derivati loro usi e kit che le comprendono.
ES1035319Y (es) Soporte para repisas, perfeccionado.